NYC Health - New York Regional Extension Center - The Primary Care Information Project

  • Home
  • What we do
  • How to Join
  • For Current Members
  • Meaningful Use
  • Contact
  • Overview
  • Eligibility
  • Criteria
  • Incentive Payments
  • Ehr Certification
  • Links

Join Now

Apply to join REACH for
EHR assistance from initial
purchase to Meaningful Use.


Join Now

Meaningful Use


CRITERIA

To get full credit for using their EHR, eligible physicians must meet 25 total measures: 15 from a "core set" and 5 out of 10 options from a "menu set." In addition, they must report on 6 clinical quality measures: 3 core quality measures and an additional 3 from a set of 38. There are no thresholds for these quality measures; providers only need to submit them to meet the requirement.

Meaningful Use Measures

Core Set - Must meet all 15
Objective Measure
Record patient demographics (sex, race, ethnicity, date of birth, preferred language) More than 50% of patients' demographic data recorded as structured data
Record vital signs and chart changes (height, weight, blood pressure, body-mass index, growth charts for children) More than 50% of patients 2 years of age or older have height, weight, and blood pressure recorded as structured data
Maintain up-to-date problem list of current and active diagnoses More than 80% of patient have at least one entry recorded as structured data
Maintain active medication list More than 80% of patient have at least one entry recorded as structured data
Maintain active medication allergy list More than 80% of patient have at least one entry recorded as structured data
Record smoking status for patients 13 years of age or older More than 50% of patients 13 years of age or older have smoking status recorded as structured data
Provide patients with clinical summaries for each office visit Clinical summaries provided to patients for more than 50% of all office visits within 3 business days
On request, provide patients with an electronic copy of their health information (including diagnostic test results, problem list, medication lists, medication allergies) More than 50% of requesting patients receive electronic copy within 3 business days
Generate and transmit permissible prescriptions electronically More than 40% are transmitted electronically using certified EHR technology
Computer provider order entry (CPOE) for medication orders More than 30% of patients with at least one medication in their medication list have at least one medication ordered through CPOE
Implement drug-drug and drug-allergy interaction checks Functionality is enabled for these checks for the entire reporting period
Implement capability to electronically exchange key clinical information among providers and patient-authorized entities Perform at least one test of EHR's capacity to electronically exchange information
Implement one clinical decision support rule and ability to track compliance with this rule Once clinical decision support rule implemented
Implement systems to protect privacy and security of patient data in the EHR Conduct or review a security risk analysis, implement security updates as necessary, and correct identified security deficiencies
Report clinical quality measures to CMS or states (Click for details on these measures) For 2011, provide aggregate numerator and denominator through attestation; for 2012, electronically submit measures
Menu Set - Must pick 5 including 1 public health measure*
Implement drug formulary checks Drug formulary check system is implemented and has access to at least one internal or external drug formulary for the entire reporting period
Incorporate clinical laboratory test results into EHRs as structure data More than 40% of clinical laboratory test results whose results are in positive/negative or numerical format are incorporated into EHRs as structured data
Generate lists of patients by specific conditions to use for quality improvement, reduction of disparities, research, or outreach Generate at least one listing of patients with a specific condition
Use EHR technology to identify patient-specific education resources and provide those to the patient as appropriate More than 10% of patients are provided patient-specific education resources
Perform medication reconciliation between care settings Medication reconciliation is performed for more than 50% of transitions of care
Provide summary of care record for patients referred or transitioned to another provider or setting Summary of care record is provided for more than 50% of patient transitions or referrals
*Submit electronic immunization data to immunization registries or immunization information systems Perform at least one test of data submission and follow-up submission (where registries can accept electronic submissions)
*Submit electronic syndromic surveillance data to public health agencies Perform at least one test of data submission and follow-up submission (where public health agencies can accept electronic data)
Send reminders to patients (per patient preference) for preventive and follow-up care More than 20% of patients 65 years of age or older or 5 years of age or younger are set appropriate reminders
Provide patients with timely electronic access to their health information (including laboratory results, problem list, medication lists, medication allergies) More than 10% of patients are provided electronic access to information within 4 days of its being updated in the EHR

 

CLINICAL QUALITY MEASURES

Meaningful Use Clinical Quality Measures
There are no performance thresholds implied; the requirement is that these measures be reported for Stage 1, not that they meet a specific value

Core Measures for ALL Physicians (Must meet 3) CQM Description Source - PQRI Source - NQF
Hypertension: Blood Pressure Measurement Percentage of patient visits for patients aged 18 years and older with a diagnosis of hypertension who have been seen for at least 2 office visits, with blood pressure (BP) recorded.   0013
Preventive Care and Screening Measure Pair: (a) Tobacco Use Assessment, (b) Tobacco Cessation Intervention The percentage of patients 18 years of age and older who were current smokers or tobacco users, who were seen by a practitioner during the measurement year and who received advice to quit smoking or tobacco use or whose practitioner recommended or discussed smoking or tobacco use cessation medications, methods or strategies.   0028
Adult Weight Screening Percentage of patients aged 18 years and older with a calculated BMI in the past six months or during the current visit documented in the medical record AND if the most recent BMI is outside parameters, a follow-up plan is documented. 128 0421
(Alternate Core Measures)
Weight Assessment and Counseling for Children and Adolescents The percentage of patients 2-17 years of age who had an outpatient visit with a PCP or OB/GYN and who had evidence of BMI percentile documentation, counseling for nutrition and counseling for physical activity during the measurement year.   0024
Preventive Care and Screening: Influenza Vaccination for Patients 50 Years Old or Older Percentage of patients aged 50 years and older who received an influenza immunization during the flu season (September through February). 110 0041
Childhood Immunization Status The percentage of children 2 years of age who had four diphtheria, tetanus and acellular pertussis (DTaP); three polio (IPV); one measles, mumps and rubella (MMR); two H influenza type B (HiB); three hepatitis B (Hep B), one chicken pox (VZV); four pneumococcal conjugate (PCV); two hepatitis A (Hep A); two or three rotavirus (RV); and two influenza (flu) vaccines by their second birthday. The measure calculates a rate for each vaccine and two separate combination rates.   0038
Additional Specialty Measure Menu (Must meet 3)
Diabetes: Hemoglobin A1c Poor Control The percentage of patients 18–75 years of age with diabetes (type 1 or type 2) who had HbA1c >9.0%. 1 0059
Diabetes: Low Density Lipoprotein (LDL) Management and Control The percentage of patients 18–75 years of age with diabetes (type 1 or type 2) who had LDL-C <100mg/dL. 2 0064
Diabetes: Blood Pressure Management The percentage of patients 18–75 years of age with diabetes (type 1 or type 2) who had BP <140/90 mmHg. 3 0061
Heart Failure (HF): Angiotensein-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Block (ARB) for Left Ventricular Dysfunction (LVSD) Percentage of patients aged 18 years and older with a diagnosis of heart failure and LVSD (LVEF < 40%) who were prescribed ACE inhibitor or ARB therapy. 5 0081
Coronary Artery Disease (CAD): Beta-Blocker Therapy for CAD Patients with Prior MI Percentage of patients aged 18 years and older with a diagnosis of CAD and prior MI who were prescribed beta-blocker therapy. 7 0070
Pneumonia Vaccination Status for Older Adults The percentage of patients 65 years of age and older as of January 1 of the measurement year who have ever received a pneumococcal vaccine. 111 0043
Breast Cancer Screening The percentage of women 40–69 years of age who had a mammogram to screen for breast cancer. 112 0031
Colorectal Cancer Screening The percentage of adults 50–75 years of age who had appropriate screening for colorectal cancer. 113 0034
Coronary Artery Disease (CAD): Oral Antiplatelet Therapy Prescribed for Patients with CAD Percentage of patients aged 18 years and older with a diagnosis of CAD who were prescribed oral antiplatelet therapy. 6 0067
Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) Percentage of patients aged 18 years and older with a diagnosis of heart failure who also have LVSD (LVEF < 40%) and who were prescribed beta-blocker therapy. 8 0083
Anti-depressant Medication Management: (a) Effective Acute Phase Treatment, (b) Effective Continuation Phase Treatment The percentage of patients 18 years of age and older who were diagnosed with a new episode of major depression, treated with antidepressant medication, and who remained on an antidepressant medication treatment. 9 0105
Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation Percentage of patients aged 18 years and older with a diagnosis of POAG who have been seen for at least 2 office visits, who have an optic nerve head evaluation during one or more office visits within 12 months. 12 0086
Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy Percentage of patients aged 18 years and older with a diagnosis of diabetic retinopathy who had a dilated macular or fundus exam performed which included documentation of the level of severity of retinopathy and the presence or absence of macular edema during one or more office visits within 12 months. 18 0088
Diabetic Retinopathy: Communication with the Physician Managing On-going Diabetes Care Percentage of patients aged 18 years and older with a diagnosis of diabetic retinopathy who had a dilated macular or fundus exam performed with documented communication to the physician who manages the on-going care of the patient with diabetes mellitus regarding the findings of the macular or fundus exam at least once within 12 months. 19 0089
Asthma Pharmacologic Therapy Percentage of patients aged 5 through 40 years with a diagnosis of mild, moderate, or severe persistent asthma who were prescribed either the preferred long-term control medication (inhaled corticosteroid) or an acceptable alternative treatment. 53 0047
Asthma Assessment Percentage of patients aged 5 through 40 years with a diagnosis of asthma and who have been seen for at least 2 office visits, who were evaluated during at least one office visit within 12 months for the frequency (numeric) of daytime and nocturnal asthma symptoms. 64 0001
Appropriate Testing for Children with Pharyngitis The percentage of children 2–18 years of age who were diagnosed with Pharyngitis, dispensed an antibiotic and received a group A streptococcus (strep) test for the episode. 66 0002
Oncology Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/Progesterone Receptor (ER/PR) Positive Breast Cancer Percentage of female patients aged 18 years and older with Stage IC through IIIC, ER or PR positive breast cancer who were prescribed tamoxifen or aromatase inhibitor (AI) during the 12-month reporting period. 71 0387
Oncology Colon Cancer: Chemotherapy for Stage III Colon Cancer Patients Percentage of patients aged 18 years and older with Stage IIIA through IIIC colon cancer who are referred for adjuvant chemotherapy, prescribed adjuvant chemotherapy, or have previously received adjuvant chemotherapy within the 12-month reporting period. 72 0385
Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low-Risk Prostate Cancer Patients Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy, OR cryotherapy who did not have a bone scan performed at any time since diagnosis of prostate cancer. 102 0389
Smoking and Tobacco Use Cessation, Medical Assistance: (a) Advising Smokers and Tobacco Users to Quit, (b) Discussing Smoking and Tobacco Use Cessation Medications, (c) Discussing Smoking and Tobacco Use Cessation Strategies The percentage of patients 18 years of age and older who were current smokers or tobacco users, who were seen by a practitioner during the measurement year and who received advice to quit smoking or tobacco use or whose practitioner recommended or discussed smoking or tobacco use cessation medications, methods or strategies. 115 0027
Diabetes: Eye Exam The percentage of patients 18–75 years of age with diabetes (type 1 or type 2) who had a retinal or dilated eye exam or a negative retinal exam (no evidence of retinopathy) by an eye care professional. 117 0055
Diabetes: Urine Screening The percentage of patients 18–75 years of age with diabetes (type 1 or type 2) who had a nephropathy screening test or evidence of nephropathy. 119 0062
Diabetes: Foot Exam The percentage of patients aged 18-75 years with diabetes (type 1 or type 2) who had a foot exam (visual inspection, sensory exam with monofilament, or pulse exam). 163 0056
Coronary Artery Disease (CAD): Drug Therapy for Lowering LDL-Cholesterol Percentage of patients aged 18 years and older with a diagnosis of CAD who were prescribed a lipid-lowering therapy (based on current ACC/AHA guidelines). 197 0074
Heart Failure (HF): Warfarin Therapy for Patients with Atrial Fibrillation Percentage of all patients aged 18 and older with a diagnosis of heart failure and paroxysmal or chronic atrial fibrillation who were prescribed warfarin therapy. 200 0084
Ischemic Vascular Disease (IVD): Blood Pressure Management The percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) from January 1–November 1 of the year prior to the measurement year, or who had a diagnosis of ischemic vascular disease (IVD) during the measurement year and the year prior to the measurement year and whose most recent blood pressure is in control (<140/90 mmHg). 201 0073
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic The percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) from January 1–November 1 of the year prior to the measurement year, or who had a diagnosis of ischemic vascular disease (IVD) during the measurement year and the year prior to the measurement year and who had documentation of use of aspirin or another antithrombotic during the measurement year. 204 0068
Initiation and Engagement of Alcohol and Other Drug Dependence Treatment: (a) Initiation, (b) Engagement The percentage of adolescent and adult patients with a new episode of alcohol and other drug (AOD) dependence who initiate treatment through an inpatient AOD admission, outpatient visit, intensive outpatient encounter or partial hospitalization within 14 days of the diagnosis and who initiated treatment and who had two or more additional services with an AOD diagnosis within 30 days of the initiation visit. NA 0004
Prenatal Screening for Human Immunodeficiency Virus (HIV) Percentage of patients, regardless of age, who gave birth during a 12-month period who were screened for HIV infection during the first or second prenatal visit.   0012
Prenatal Anti-D Immune Globulin Percentage of D (Rh) negative, unsensitized patients, regardless of age, who gave birth during a 12-month period who received anti-D immune globulin at 26-30 weeks gestation.   0014
Controlling High Blood Pressure The percentage of patients 18‐85 years of age who had a diagnosis of hypertension and whose BP was adequately controlled during the measurement year.   0018
Cervical Cancer Screening The percentage of women 21-64 years of age who received one or more Pap tests to screen for cervical cancer.   0032
Chlamydia Screening in Women The percentage of women 15-24 years of age who were identified as sexually active and who had at least one test for chlamydia during the measurement year.   0033
Use of Appropriate Medications for Asthma The percentage of patients 5-50 years of age during the measurement year who were identified as having persistent asthma and were appropriately prescribed medication during the measurement year. Report three age stratifications (5-11 years, 12-50 years, and total).   0036
Low Back Pain: Use of Imaging Studies The percentage of patients with a primary diagnosis of low back pain who did not have an imaging study (plain X-ray, MRI, CT scan) within 28 days of diagnosis.   0052
Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control The percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) from January 1–November 1 of the year prior to the measurement year, or who had a diagnosis of ischemic vascular disease (IVD) during the measurement year and the year prior to the measurement year and who had a complete lipid profile performed during the measurement year and whose LDL-C was <100 mg/dL.   0075
Diabetes Care: Hemoglobin A1c Control (<8.0%) The percentage of patients 18–75 years of age with diabetes (type 1 or type 2) who had HbA1c <8.0%. NA 0575


  • Home
  • What We Do
  • How to Join
  • For Current Members
  • Meaningful Use

  • About Us
  • FAQs
  • News
  • Contact Us
©2012 The Fund for Public Health in New York, Inc.